The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Drug-Device Combination Products Market Research Report 2025

Global Drug-Device Combination Products Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1413983

No of Pages : 102

Ask Your Query

Synopsis

Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.

The global Drug-Device Combination Products market was valued at US$ 35200 million in 2023 and is anticipated to reach US$ 53720 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.

Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific.
In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.

This report aims to provide a comprehensive presentation of the global market for Drug-Device Combination Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-Device Combination Products.

Report Scope

The Drug-Device Combination Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug-Device Combination Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug-Device Combination Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • GSK
  • Novo Nordisk
  • Eli Lilly
  • AstraZeneca
  • Sanofi
  • Boston Scientific
  • Abbott
  • Boehringer Ingelheim
  • Medtronic
  • Mylan
  • 3M
  • Hisamitsu
  • Smith & Nephew
  • Molnlycke
  • Teleflex
  • BD
  • Lepu Medical
  • MicroPort
  • Terumo
  • B. Braun
  • Antares Pharma

Segment by Type

  • Drug-Coated Device
  • Prefilled Drug Delivery Systems
  • Nebulizer and Inhaler
  • Transdermal Delivery System
  • Others

Segment by Application

  • Hospital andClinic
  • Retail Pharmacies
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug-Device Combination Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug-Device Combination Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Drug-Coated Device
1.2.3 Prefilled Drug Delivery Systems
1.2.4 Nebulizer and Inhaler
1.2.5 Transdermal Delivery System
1.2.6 Others
1.3 Market by Application
1.3.1 Global Drug-Device Combination Products Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital andClinic
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug-Device Combination Products Market Perspective (2019-2030)
2.2 Drug-Device Combination Products Growth Trends by Region
2.2.1 Global Drug-Device Combination Products Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug-Device Combination Products Historic Market Size by Region (2019-2024)
2.2.3 Drug-Device Combination Products Forecasted Market Size by Region (2025-2030)
2.3 Drug-Device Combination Products Market Dynamics
2.3.1 Drug-Device Combination Products Industry Trends
2.3.2 Drug-Device Combination Products Market Drivers
2.3.3 Drug-Device Combination Products Market Challenges
2.3.4 Drug-Device Combination Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug-Device Combination Products Players by Revenue
3.1.1 Global Top Drug-Device Combination Products Players by Revenue (2019-2024)
3.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2019-2024)
3.2 Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug-Device Combination Products Revenue
3.4 Global Drug-Device Combination Products Market Concentration Ratio
3.4.1 Global Drug-Device Combination Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug-Device Combination Products Revenue in 2023
3.5 Drug-Device Combination Products Key Players Head office and Area Served
3.6 Key Players Drug-Device Combination Products Product Solution and Service
3.7 Date of Enter into Drug-Device Combination Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug-Device Combination Products Breakdown Data by Type
4.1 Global Drug-Device Combination Products Historic Market Size by Type (2019-2024)
4.2 Global Drug-Device Combination Products Forecasted Market Size by Type (2025-2030)
5 Drug-Device Combination Products Breakdown Data by Application
5.1 Global Drug-Device Combination Products Historic Market Size by Application (2019-2024)
5.2 Global Drug-Device Combination Products Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug-Device Combination Products Market Size (2019-2030)
6.2 North America Drug-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug-Device Combination Products Market Size by Country (2019-2024)
6.4 North America Drug-Device Combination Products Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug-Device Combination Products Market Size (2019-2030)
7.2 Europe Drug-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug-Device Combination Products Market Size by Country (2019-2024)
7.4 Europe Drug-Device Combination Products Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug-Device Combination Products Market Size (2019-2030)
8.2 Asia-Pacific Drug-Device Combination Products Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug-Device Combination Products Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug-Device Combination Products Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug-Device Combination Products Market Size (2019-2030)
9.2 Latin America Drug-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug-Device Combination Products Market Size by Country (2019-2024)
9.4 Latin America Drug-Device Combination Products Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug-Device Combination Products Market Size (2019-2030)
10.2 Middle East & Africa Drug-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug-Device Combination Products Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug-Device Combination Products Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Drug-Device Combination Products Introduction
11.1.4 GSK Revenue in Drug-Device Combination Products Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Detail
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Drug-Device Combination Products Introduction
11.2.4 Novo Nordisk Revenue in Drug-Device Combination Products Business (2019-2024)
11.2.5 Novo Nordisk Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Drug-Device Combination Products Introduction
11.3.4 Eli Lilly Revenue in Drug-Device Combination Products Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Drug-Device Combination Products Introduction
11.4.4 AstraZeneca Revenue in Drug-Device Combination Products Business (2019-2024)
11.4.5 AstraZeneca Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Drug-Device Combination Products Introduction
11.5.4 Sanofi Revenue in Drug-Device Combination Products Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Boston Scientific
11.6.1 Boston Scientific Company Detail
11.6.2 Boston Scientific Business Overview
11.6.3 Boston Scientific Drug-Device Combination Products Introduction
11.6.4 Boston Scientific Revenue in Drug-Device Combination Products Business (2019-2024)
11.6.5 Boston Scientific Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Drug-Device Combination Products Introduction
11.7.4 Abbott Revenue in Drug-Device Combination Products Business (2019-2024)
11.7.5 Abbott Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Drug-Device Combination Products Introduction
11.8.4 Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2019-2024)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Detail
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Drug-Device Combination Products Introduction
11.9.4 Medtronic Revenue in Drug-Device Combination Products Business (2019-2024)
11.9.5 Medtronic Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Drug-Device Combination Products Introduction
11.10.4 Mylan Revenue in Drug-Device Combination Products Business (2019-2024)
11.10.5 Mylan Recent Development
11.11 3M
11.11.1 3M Company Detail
11.11.2 3M Business Overview
11.11.3 3M Drug-Device Combination Products Introduction
11.11.4 3M Revenue in Drug-Device Combination Products Business (2019-2024)
11.11.5 3M Recent Development
11.12 Hisamitsu
11.12.1 Hisamitsu Company Detail
11.12.2 Hisamitsu Business Overview
11.12.3 Hisamitsu Drug-Device Combination Products Introduction
11.12.4 Hisamitsu Revenue in Drug-Device Combination Products Business (2019-2024)
11.12.5 Hisamitsu Recent Development
11.13 Smith & Nephew
11.13.1 Smith & Nephew Company Detail
11.13.2 Smith & Nephew Business Overview
11.13.3 Smith & Nephew Drug-Device Combination Products Introduction
11.13.4 Smith & Nephew Revenue in Drug-Device Combination Products Business (2019-2024)
11.13.5 Smith & Nephew Recent Development
11.14 Molnlycke
11.14.1 Molnlycke Company Detail
11.14.2 Molnlycke Business Overview
11.14.3 Molnlycke Drug-Device Combination Products Introduction
11.14.4 Molnlycke Revenue in Drug-Device Combination Products Business (2019-2024)
11.14.5 Molnlycke Recent Development
11.15 Teleflex
11.15.1 Teleflex Company Detail
11.15.2 Teleflex Business Overview
11.15.3 Teleflex Drug-Device Combination Products Introduction
11.15.4 Teleflex Revenue in Drug-Device Combination Products Business (2019-2024)
11.15.5 Teleflex Recent Development
11.16 BD
11.16.1 BD Company Detail
11.16.2 BD Business Overview
11.16.3 BD Drug-Device Combination Products Introduction
11.16.4 BD Revenue in Drug-Device Combination Products Business (2019-2024)
11.16.5 BD Recent Development
11.17 Lepu Medical
11.17.1 Lepu Medical Company Detail
11.17.2 Lepu Medical Business Overview
11.17.3 Lepu Medical Drug-Device Combination Products Introduction
11.17.4 Lepu Medical Revenue in Drug-Device Combination Products Business (2019-2024)
11.17.5 Lepu Medical Recent Development
11.18 MicroPort
11.18.1 MicroPort Company Detail
11.18.2 MicroPort Business Overview
11.18.3 MicroPort Drug-Device Combination Products Introduction
11.18.4 MicroPort Revenue in Drug-Device Combination Products Business (2019-2024)
11.18.5 MicroPort Recent Development
11.19 Terumo
11.19.1 Terumo Company Detail
11.19.2 Terumo Business Overview
11.19.3 Terumo Drug-Device Combination Products Introduction
11.19.4 Terumo Revenue in Drug-Device Combination Products Business (2019-2024)
11.19.5 Terumo Recent Development
11.20 B. Braun
11.20.1 B. Braun Company Detail
11.20.2 B. Braun Business Overview
11.20.3 B. Braun Drug-Device Combination Products Introduction
11.20.4 B. Braun Revenue in Drug-Device Combination Products Business (2019-2024)
11.20.5 B. Braun Recent Development
11.21 Antares Pharma
11.21.1 Antares Pharma Company Detail
11.21.2 Antares Pharma Business Overview
11.21.3 Antares Pharma Drug-Device Combination Products Introduction
11.21.4 Antares Pharma Revenue in Drug-Device Combination Products Business (2019-2024)
11.21.5 Antares Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock